Canara HSBC (CANHLIFE)

Fast Grower

FairStock Score: 20/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹148.71
Market Cap₹14,090.05 Cr
P/E Ratio107.76
ROCE8.73%
ROE8.28%
Dividend Yield0.27%
Profit Growth21.7%
Debt/Equity0.15
Sales Growth20.4%
Promoter Holding62%
52-Week Range₹106 — ₹166.5
SectorInsurance
Book Value₹17.42

Strengths

Concerns

AI Analysis

At ₹146.45, Mr. Market is asking me to pay 118 times earnings and 8.89 times book value for Canara HSBC. Graham would call that margin of safety? No. The company grew sales 177%, but profits fell 5.70%—and the latest quarter’s ₹28 Cr profit on ₹4,202 Cr revenue is a net margin near 0.7%. That is top-line hope, not bottom-line proof. ROE of 8.11% is unexciting, especially after paying nearly nine times book for an insurer earning returns below my required rate. The Piotroski F-score of 4/9 reinforces my unease: low score means weak internal signals, not a fortress. I cannot calculate a traditional debt/equity for a life insurer, so I rely on earnings quality and margins; both are thin. Promoter holding at 62% does align interests, and the 52-week range shows the stock is not at an extreme high, but the valuation still leaves no room for error. The PEG of 0.67 looks seductive, but it is built on a 177% sales growth figure that is not translating into shareholder profits; Graham preferred profit growth with demonstrable earnings, not merely premium inflows. With no dividend, the investor gets no compensation while waiting. In my circle, I want predictable earnings power and a fair price. Here I see market enthusiasm pricing perfection into a business earning mediocre ROE. If the profit can catch up with the growth, the story changes; until then, this is a high-risk growth story, not a value investment.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer